Blood Sample Collection From Pregnant Women at Increased Risk for Fetal Chromosome Abnormality
Status: openCollection of Whole Blood Specimens from Pregnant Women at Increased Risk for Fetal Chromosomal Abnormality for use in Development of a Noninvasive Prenatal Test in Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted From Maternal Plasma
Treatment for Fetal Aneuploidy / Down Syndrome
Description
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Sponsors
This trial is sponsored by Sequenom, Inc..Interested in Clinical Trial?
Contact the Clinical Trial Coordinator
If you have questions get in touch with this Clinical Trial’s Coordinator by phone at 251-415-1598 or by email at marmistead@health.southalabama.edu.
Providers Associated With This Trial
Principle Investigator
![Susan Baker]()
View ProfileSusan L. Baker, M.D.Maternal-Fetal PhysicianDirector of Maternal Fetal Medicine Division; Associate Professor of Obstetrics and Gynecology
This link will open in a new tab or window.